Metformin Stada (Metformin Hydrochloride)

Metformin reduces hepatic gluconeogenesis by inhibiting mitochondrial complex I, which lowers glucose output from the liver. It also activates AMP‑activated protein kinase, enhancing insulin‑mediated glucose uptake in muscle and fat tissue, and modestly reduces intestinal glucose absorption, collectively lowering blood sugar levels.

The appropriate dose of Metformin Stada is determined by the prescribing healthcare professional based on the individual’s clinical condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety of metformin during pregnancy or lactation depends on clinical judgment. While some guidelines allow its use when benefits outweigh risks, the decision should be made by a qualified healthcare provider who can evaluate the specific circumstances of the mother and infant.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin belongs to the biguanide class and is often first‑line therapy for type 2 diabetes because it does not stimulate insulin secretion, has a low risk of hypoglycemia when used alone, and may aid weight management. Other classes, such as sulfonylureas or insulin, act by increasing insulin levels and may carry higher hypoglycemia risk.

Metformin Stada should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Metformin Stada is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets are swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare provider and not crush or chew the tablets unless specifically instructed.

The most serious adverse reaction is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or conditions causing hypoxia. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metformin Stada is contraindicated in individuals with known hypersensitivity to metformin, severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in patients with conditions that predispose to hypoxia without appropriate medical supervision.